News | July 02, 2022
Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
HealthCare Royalty Partners funding supports the ongoing launch of IBSRELA in the United States
Innate to receive $5M milestone payment from AstraZeneca
The plan is to advance innovative therapies to drug-resistant cancers
An estimated 21 million American women experience BV
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The company has 271 cumulative ANDA filings with USFDA of which 243 ANDAs have been approved and 28 are pending approval
A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies
The company has developed the API in house at its R&D center in Hyderabad
The proposed acquisition offers a potentially new, differentiated best-in-class approach to address the unmet need for a broader number of patients with immuno-inflammatory diseases
Clindamycin Phosphate Foam, 1% is the generic version of Evoclin Foam, 1%
Subscribe To Our Newsletter & Stay Updated
